Cargando…
Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors
Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer and disproportionately accounts for the majority of breast cancer related deaths. Effective treatment of this disease remains an unmet medical need. Over the past several decades, TNBC cell lines have been used as t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762590/ https://www.ncbi.nlm.nih.gov/pubmed/29348905 http://dx.doi.org/10.18632/oncotarget.22916 |